LONDON (Reuters) - Hospira has successfully overturned two patents on Roche's top-selling breast cancer drug Herceptin in Britain, clearing the way for it to launch a cheaper copycat version in the country.
via Reuters: Health News Read More Here..
No comments:
Post a Comment